Cargando…
The distinct role of CD4(+) and CD8(+) T-cells during the anti-tumour effects of targeted superantigens
To target T-cells to the tumour area we created a recombinant protein of the bacterial superantigen (SAg) Staphylococcal enterotoxin A (SEA) and the Fab-fragment of a tumour-reactive antibody. This antibody-targeted SAg immunotherapy therapy has been shown to be highly efficient, eliminating > 95...
Autores principales: | Litton, M J, Dohlsten, M, Rosendahl, A, Ohlsson, L, Søgaard, M, Andersson, J, Andersson, U |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362868/ https://www.ncbi.nlm.nih.gov/pubmed/10496366 http://dx.doi.org/10.1038/sj.bjc.6690701 |
Ejemplares similares
-
Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen
por: Forsberg, G, et al.
Publicado: (2001) -
Trafficking of ‘immune’ CD4(+)/CD8(+) T-lymphocytes into the RENCA tumour microcirculation in vivo in mice
por: Ali, S A, et al.
Publicado: (2000) -
Enhanced expression of IFN- γ mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer
por: Elsässer-Beile, U, et al.
Publicado: (2000) -
CD28: Direct and Critical Receptor for Superantigen Toxins
por: Kaempfer, Raymond, et al.
Publicado: (2013) -
Bacterial Superantigen Toxins, CD28, and Drug Development
por: Kaempfer, Raymond
Publicado: (2018)